Table 1.
Study | Study Design | Case N |
Control N |
Male N |
Female N |
Age Range |
Colon Cancer N |
Rectal Cancer N |
Total N |
---|---|---|---|---|---|---|---|---|---|
CCFR | Case-control | 1163 | 977 | 1072 | 1068 | 20–81 | 445 | 286 | 2140 |
Colo 2&3 | Case-control | 87 | 125 | 117 | 95 | 38–86 | 59 | 27 | 212 |
DACHS | Case-control | 2376 | 2206 | 2752 | 1830 | 33–99 | 1422 | 949 | 4582 |
DALS | Case-control | 1116 | 1174 | 1261 | 1029 | 28–79 | 1112 | 0 | 2290 |
HPFS | Nested case- control |
173 | 230 | 403 | 0 | 48–81 | 113 | 41 | 403 |
MEC | Nested case- control |
328 | 346 | 361 | 313 | 45–76 | 241 | 81 | 674 |
NHS | Nested case- control |
375 | 955 | 0 | 1330 | 44–69 | 285 | 86 | 1330 |
PHS | Nested case- control |
375 | 389 | 764 | 0 | 40–85 | 286 | 84 | 764 |
PLCO | Nested case- control |
486 | 415 | 518 | 383 | 55–75 | 320 | 161 | 901 |
PMH-CCFR | Case-control | 280 | 122 | 0 | 402 | 48–73 | 206 | 64 | 402 |
OFCCR | Case-control | 650 | 522 | 562 | 610 | 29–77 | 433 | 197 | 1172 |
VITAL | Nested case- control |
285 | 288 | 300 | 273 | 50–76 | 215 | 66 | 573 |
WHI | Nested case- control |
1466 | 1531 | 0 | 2997 | 50–79 | 1149 | 261 | 2997 |
Total | 9160 | 9280 | 8110 | 10330 | 20–99 | 6286 | 2303 | 18440 |